azmed-academy.com.mx valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | AstraZeneca - Research-Based BioPharmaceutical |
| Description | Science AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 165.160.15.20 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
azmed-academy.com.mx Valuation
|
US$955
Last updated: 2022-12-23 01:56:39
azmed-academy.com.mx has Semrush global rank of 0. azmed-academy.com.mx has an estimated worth of US$ 955, based on its estimated Ads revenue. azmed-academy.com.mx receives approximately 110 unique visitors each day. Its web server is located in United States, with IP address 165.160.15.20. According to SiteAdvisor, azmed-academy.com.mx is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$955 |
| Daily Ads Revenue | US$0 |
| Monthly Ads Revenue | US$26 |
| Yearly Ads Revenue | US$317 |
| Daily Unique Visitors | 7 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| azmed-academy.com.mx. | A | 14400 | IP: 165.160.15.20 |
| azmed-academy.com.mx. | A | 14400 | IP: 165.160.13.20 |
| azmed-academy.com.mx. | NS | 14400 | NS Record: dns1.cscdns.net. |
| azmed-academy.com.mx. | NS | 14400 | NS Record: dns2.cscdns.net. |
| azmed-academy.com.mx. | MX | 14400 | MX Record: 10 custmx.cscdns.net. |
HtmlToTextCheckTime:2022-12-23 01:56:39
| Skip to content Skip to navigation Skip to footer Search Menu Search Search Search Close What science can do R&D R&D Our approach Precision medicine Transformative science Data science & AI Digital health Our technologies Next generation therapeutics Publications R&D strategic centres Our therapy areas All therapy areas Oncology BioPharmaceuticals Cardiovascular, Renal and Metabolism Respiratory & Immunology Vaccines and Immune Therapies Rare Disease Pipeline All medicines Our company Our company Our people Our commitment to patients Our leadership Cambridge Gothenburg Gaithersburg Careers Careers website Working with us Inclusion and diversity Investors Investor Relations (Global) Investor Relations (Sweden) Resources Governance Shareholder information Dividend policy Key facts FAQs Debt Investors ADR Programme Media Press Releases Media centre Statements Articles Image library COVID-19 resources Broadcast videos Archive Media contacts Sustainability Sustainability Access to |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Thu, 06 Oct 2022 08:19:07 GMT Location: https://www.astrazeneca.com/ Content-Length: 0 HTTP/2 200 content-type: text/html;charset=utf-8 date: Thu, 06 Oct 2022 08:19:08 GMT set-cookie: AWSALB=h9M10KKChIZJoVCLQ2WrpaOM1dc84xUD4YvyjRf9gyZwLEiYYo438qeUrak4ZNeyF+rHXS+KbsqiHr3HHbxK0vy+13JfxWrkq5fOax9j7BSY/Tn2MsGopD6j6qcm; Expires=Thu, 13 Oct 2022 08:19:08 GMT; Path=/ set-cookie: AWSALBCORS=h9M10KKChIZJoVCLQ2WrpaOM1dc84xUD4YvyjRf9gyZwLEiYYo438qeUrak4ZNeyF+rHXS+KbsqiHr3HHbxK0vy+13JfxWrkq5fOax9j7BSY/Tn2MsGopD6j6qcm; Expires=Thu, 13 Oct 2022 08:19:08 GMT; Path=/; SameSite=None; Secure server: Apache strict-transport-security: max-age=31536000; includeSubDomains cache-control: max-age=0, no-cache x-cache: Miss from cloudfront via: 1.1 8ea75fde43c768e7e1d041f8b7a07bd6.cloudfront.net (CloudFront) x-amz-cf-pop: ARN56-P1 x-amz-cf-id: gaHgQ8QEhurL_UMTt9euwyhcOuuixiHBMwsPlxQpyESQAqSTwDrHpg== |